Evidence map›Paper›PMID 33093060›Full record

ArticleBMJ case reports2020

Diagnosis of oesophageal mucormycosis managed with medical therapy alone.

Matthew Ringer, Lauren Pischel, Marwan Mikheal Azar

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. OesophagealMedical mycology case reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Matthew RingerInternal Medicine, Yale New Haven Health System, New Haven, Connecticut, USA matthew.ringer@yale.edu.ORCID http://orcid.org/0000-0002-3211-5609
Lauren PischelDepartment of Internal Medicine, Section of Infectious Disease, Yale New Haven Health System, New Haven, Connecticut, USA.
Marwan Mikheal AzarYale University School of Medicine, Yale New Haven Health System, New Haven, Connecticut, USA.ORCID http://orcid.org/0000-0001-5498-5042
Yale New Haven Health System · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
TRAINING IN THE PATHOGENESIS OF INFECTIOUS DISEASEST32AI007517 · NIAID · YALE UNIVERSITY · PI Jaimie Meyer, Albert C Shaw · 1997 to 2026
$6.1M
NCATS NIH HHS UL1 TR001863NIAID NIH HHS T32 AI007517
6 · The paper itself

Abstract

Mucormycosis is an invasive mould that can cause aggressive infection, particularly in immunocompromised patients. Though oesophageal mucormycosis is relatively rare, it remains an elusive and devastating manifestation of this disease. The management is also challenging, due to surgical morbidity and contraindications such as thrombocytopenia in immunocompromised hosts. In this report, we present the case of a 60-year-old Lebanese man with newly diagnosed acute myeloid leukaemia who developed oesophageal mucormycosis after induction chemotherapy with idarubicin/cytarabine (7+3). The diagnosis was made when the patient developed febrile neutropenia and odynophagia. CT scan of the chest revealed a thickened oesophagus. Oesophagogastroduodenoscopy with biopsy, histopathology and PCR were performed, resulting in the diagnosis of

Indexed as

Immunocompromised HostAmphotericin BAntifungal AgentsCytarabineEsophageal DiseasesEsophagusHumansIdarubicinInduction ChemotherapyLeukemia, Myeloid, AcuteMaleMiddle AgedMucormycosisRhizopusTriazolesAmphotericin BAntifungal AgentsCytarabineIdarubicinliposomal amphotericin BposaconazoleTriazoleshaematology (incl blood transfusion)infection (gastroenterology)infectionsinfectious diseases

Identifiers

PMID33093060
PMCPMC7583061
OpenAlexW3094611847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.